Potent antihyperglycemic and hypoglycemic effect of Tamarix articulata Vahl. in normal and streptozotocin-induced diabetic rats

Biomedicine and Pharmacotherapy

Volumn 87, Issue , 2017, Pages 230-239

  Hebi, Morad ^a   Farid, Omra ^a   Ajebli, Mohammed ^a   Eddouks, Mohamed ^a  

^a MOULAY ISMAIL UNIVERSITY   (Morocco)

Author keywords

Antioxydant activity; Aqueous extract; Diabetes; Streptozotocin; Tamarix articulata

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; ANTIDIABETIC AGENT; ANTIOXIDANT; BUTYLCRESOL; GLIBENCLAMIDE; PLANT EXTRACT; TAMARIX ARTICULATA EXTRACT; UNCLASSIFIED DRUG; GLUCOSE BLOOD LEVEL; STREPTOZOCIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DPPH RADICAL SCAVENGING ASSAY; DRUG BLOOD LEVEL; DRUG ISOLATION; DRUG REEXPOSURE; GLUCOSE BLOOD LEVEL; GLUCOSE INTAKE; GLUCOSE TOLERANCE; HISTOPATHOLOGY; IC50; LIVER TISSUE; LOW DRUG DOSE; MALE; MEDICINAL PLANT; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET; PANCREAS TISSUE; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TAMARIX ARTICULATA; ANIMAL; CHEMICALLY INDUCED; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; ISOLATION AND PURIFICATION; METABOLISM; PLANT STRUCTURES; TAMARICACEAE; WISTAR RAT;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; HYPOGLYCEMIC AGENTS; MALE; PLANT COMPONENTS, AERIAL; PLANT EXTRACTS; RATS; RATS, WISTAR; STREPTOZOCIN; TAMARICACEAE;

EID: 85009062948     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2016.12.111     Document Type: Article

References (30)

1. [1] Scobie, I.N., Atlas of Diabetes Mellitus. 2007, Informa (Third Edition).
2. [2] Jarald, E., Joshi, S.B., Jain DC: diabetes and herbal medicines. Iran. J. Pharmacol. Ther. 7 (2008), 97–106.
3. [3] Shelbaya, S., Amer, H., Seddik, S., Study of the role of interleukin-6 and highly sensitive C-reactive protein in diabetic nephropathy in type 1 diabetic patients. Eur. Rev. Med. Pharmacol. Sci. 16 (2012), 176–182.
4. [4] Eddouks, M., Maghrani, M., Lemhadri, A., Ouahidi, M.L., Jouad, H., Ethnopharmacological survey of medicinal plants used for the treatment of diabetes mellitus, hypertension and cardiac diseases in the south-east region of Morocco (Tafilalet). J. Ethnopharmacol. 82 (2002), 97–103.
5. [5] Raza, M., Choudhary, M.I., Rahman, A.U., Medicinal plants with anticonvulsant activities. Stud. Nat. Prod. Chem. 22 (2000), 752–770.
6. [6] Merzouki, A., derfoufi, F.E., Mesa, J.M., Contribution to the knowledge of Rifian traditional medicine. II: Folk medicine in Ksar Lakbir district NW Morocco. Fitoterapia 71 (2000), 278–307.
7. [7] El-Ansari, M.A., Nawaar, M.A., El-Dein, A., El-Sherbeiny, A., El Sissi, H.I., A sulphated Kaempferol 7, 4’- dimethyl ether and a quercetin isoferulyl glucuronide from the flowers of Tamarix aphylla. Phytochemistry 15 (1976), 231–232.
8. [8] Barkat, H.H., Nanda, S.A., Chemical and biological investigation pf constituent Phenolics of two Egyptian folk medicinal plants- A novel phenolic from the galls of Tamarix aphylla. Nat. Prod. 9 (1996), 6–101.
9. [9] Merfort, I., Buddrus, J., Nawwar, M.A.M., Lambert, J., A triterpene from the bark of Tamarix aphylla. Phytochemistry 31 (1992), 4031–4032.
10. [10] Nawwar, M.A., Husein, S.A., Ayoub, N.A., Hofmann, K., Linscheid, M., Harms, M., Lindequist, U., Aphyllin, the first isoferulic acid glycoside and other phenolics from Tamarix aphylla flowers. Pharmazie 64 (2009), 342–347.
11. [11] Rastogi, R.P., Mehrotra, B.N., Isolation and structure determination of new ellagitannin from the galls of Tamarix aphylla. Compend. Indian Med. Plants, 5, 1994, 828.
12. [12] Ishak, M., Elsissi, I.H., Nawwar, M.A., Eisherbieny, A.E.A., Tannins and polyphenolics of galls of the Tamarix aphylla. Planta Med. 2 (1972), 246–255.
13. [13] Kumar, V., Ahmed, D., Gupta, P.S., Anwar, F., Mujeeb, M., Anti-diabetic, anti-oxidant and anti-hyperlipidemic activities of Melastoma malabathricum Linn. leaves in streptozotocin induced diabetic rats. BMC Complement. Altern. Med., 13(1), 2013, 1.
14. [14] Trinder, P., Determination of glucose in blood using glucose oxidase with on alternative oxygen receptor. Ann. Clin. Biochem., 6, 1969, 24.
15. [15] Blois, M.S., Antioxidant Determinations by the Use of a Stable Free Radical. 1958.
16. [16] Hebi, M., Eddouks, M., Évaluation de l'activité antioxydante de Stevia rebaudiana. Phytothérapie 14:1 (2016), 17–22.
17. [17] Kolterman, O.G., Gray, R.S., Shapiro, G., Scarlett, J.A., Griffin, J., Olefsky, J.M., The acute and chronic effects of sulfonylurea therapy in type II diabetic subjects. Diabetes 33:4 (1984), 346–354.
18. [18] Lebovitz, H.E., Feinglos, M.N., Bucholtz, H.K., Lebovitz, F.L., Potentiation of insulin action: a probable mechanism for the anti-diabetic action of sulfonylurea drugs. J. Clin. Endocrinol. Metab. 45:3 (1977), 601–604.
19. [19] Simonson, D.C., Ferrannini, E., Bevilacqua, S., Smith, D., Barrett, E., Carlson, R., DeFronzo, R.A., Mechanism of improvement in glucose metabolism after chronic glyburide therapy. Diabetes 33:9 (1984), 838–845.
20. [20] Chitra, V., Leelamma, S., Coriandrum sativum-mechanism of hypoglycemic action. Food Chem. 67 (1999), 229–231.
21. [21] Gelfand, R.A., DeFronzo, R.A., Hypoglycemic counterregulation in normal and diabetic man. Ann. Clin. Res. 16 (1984), 84–93.
22. [22] Cryer, P.E., Gerich, J.E., Glucose counterregulation, hypoglycemia and intensive insulin therapy in diabetes mellitus. N. Engl. J. Med. 313 (1985), 232–241.
23. [23] Wolff, S.P., Diabetes mellitus and free radicals Free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications. Br. Med. Bull. 49 (1993), 642–652.
24. [24] Ceriello, A., Postprandial hyperglycemia and diabetes complications is it time to treat?. Diabetes 54:1 (2005), 1–7.
25. [25] Mansouri, M.T., Soltani, M., Naghizadeh, B., Farbood, Y., Mashak, A., Sarkaki, A., A possible mechanism for the anxiolytic-like effect of gallic acid in the rat elevated plus maze. Pharmacol. Biochem. Behav. 117 (2014), 40–46.
26. [26] Latha, R.C., Daisy, P., Insulin secretagogue, antihyperlipidemic and other protective effects of gallic acid isolated from Terminalia bellerica Roxb. in streptozotocin induced diabetic rats. Chem. Biol. Interact. 189 (2011), 112–118.
27. [27] Punithavathi, V.R., Prince, P.S.M., Kumar, R., Selvakumari, J., Antihyperglycaemic, antilipid peroxidative and antioxidant effects of gallic acid on streptozotocin induced diabetic Wistar rats. Eur. J. Pharmacol. 650 (2011), 465–471.
28. [28] Gandhi, G.R., Jothi, G., Antony, P.J., Balakrishna, K., Paulraj, M.G., Ignacimuthu, S., Stalin, A., Al-Dhabi, N.A., Gallic acid attenuates high-fat diet fed-streptozotocin-induced insulin resistance via partial agonism of PPARγ in experimental type 2 diabetic rats and enhances glucose uptake through translocation and activation of GLUT4 in PI3 K/p-Akt signaling pathway. Eur. J. Pharmacol. 745 (2014), 201–216.
29. [29] Yuan, M., Konstantopoulos, N., Lee, J., Reversal of obesity and diet induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293 (2001), 1673–1677.
30. [30] Ramesh, B.K., Maddirala, D.R., Vinay, K.K., Shaik, S.F., Tiruvenkata, K.E.G., Swapna, S., Ramesh, B., Rao, C.A., Antihyperlipidemic activities of methanol: water (4:1) fraction isolated from aqueous extract of Syzygium alternifolium seeds in streptozotocin-induced diabetic rats. Food Chem. Toxicol. 48 (2010), 1078–1084.